Literature DB >> 29405480

Diverse actions of the modulatory peptide neurotensin on central synaptic transmission.

Christopher W Tschumi1, Michael J Beckstead1.   

Abstract

Neurotensin (NT) is a 13 amino acid neuropeptide that is expressed throughout the central nervous system and is implicated in the etiology of multiple diseases and disorders. Many primary investigations of NT-induced modulation of neuronal excitability at the level of the synapse have been conducted, but they have not been summarized in review form in nearly 30 years. Therefore, the goal of this review is to discuss the many actions of NT on neuronal excitability across brain regions as well as NT circuit architecture. In the basal ganglia as well as other brain nuclei, NT can act through diverse intracellular signaling cascades to enhance or depress neuronal activity by modulating activity of ion channels, ionotropic and metabotropic neurotransmitter receptors, and presynaptic release of neurotransmitters. Further, NT can produce indirect effects by evoking endocannabinoid release, and recently has itself been identified as a putative retrograde messenger. In the basal ganglia, the diverse actions and circuit architecture of NT signaling allow for input-specific control of reward-related behaviors.
© 2018 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990VTAzzm321990; endocannabinoids; methamphetamine; neuropeptide; substantia nigra

Year:  2018        PMID: 29405480      PMCID: PMC6078827          DOI: 10.1111/ejn.13858

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  102 in total

1.  Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody.

Authors:  A Fassio; G Evans; R Grisshammer; J P Bolam; M Mimmack; P C Emson
Journal:  Neuropharmacology       Date:  2000-06-08       Impact factor: 5.250

Review 2.  Stress and the inflammatory response: a review of neurogenic inflammation.

Authors:  Paul H Black
Journal:  Brain Behav Immun       Date:  2002-12       Impact factor: 7.217

3.  Effects of neurotensin on discharge rates of rat suprachiasmatic nucleus neurons in vitro.

Authors:  A N Coogan; N Rawlings; S M Luckman; H D Piggins
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

4.  Neurotensin excitation of serotonergic neurons in the rat nucleus raphe magnus: ionic and molecular mechanisms.

Authors:  A H Li; T H Yeh; P P Tan; H M Hwang; H L Wang
Journal:  Neuropharmacology       Date:  2001-06       Impact factor: 5.250

5.  Activation and functional characterization of the mosaic receptor SorLA/LR11.

Authors:  L Jacobsen; P Madsen; C Jacobsen; M S Nielsen; J Gliemann; C M Petersen
Journal:  J Biol Chem       Date:  2001-04-09       Impact factor: 5.157

6.  Confirmation of correlations and common quantitative trait loci between neurotensin receptor density and hypnotic sensitivity to ethanol.

Authors:  V G Erwin; V M Gehle; K Davidson; R A Radcliffe
Journal:  Alcohol Clin Exp Res       Date:  2001-12       Impact factor: 3.455

7.  Evidence for the dual coupling of the rat neurotensin receptor with pertussis toxin-sensitive and insensitive G-proteins.

Authors:  P Gailly; M Najimi; E Hermans
Journal:  FEBS Lett       Date:  2000-10-20       Impact factor: 4.124

8.  Neuronal localization of a novel mosaic apolipoprotein E receptor, LR11, in rat and human brain.

Authors:  Y Motoi; T Aizawa; S Haga; S Nakamura; Y Namba; K Ikeda
Journal:  Brain Res       Date:  1999-07-03       Impact factor: 3.252

9.  Neurotensin excites periaqueductal gray neurons projecting to the rostral ventromedial medulla.

Authors:  A H Li; H M Hwang; P P Tan; T Wu; H L Wang
Journal:  J Neurophysiol       Date:  2001-04       Impact factor: 2.714

10.  Distribution of NTS3 receptor/sortilin mRNA and protein in the rat central nervous system.

Authors:  Philippe Sarret; Pascale Krzywkowski; Laura Segal; Morten S Nielsen; Claus M Petersen; Jean Mazella; Thomas Stroh; Alain Beaudet
Journal:  J Comp Neurol       Date:  2003-07-07       Impact factor: 3.215

View more
  10 in total

Review 1.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

Review 2.  Neurotensin in reward processes.

Authors:  María Luisa Torruella-Suárez; Zoe A McElligott
Journal:  Neuropharmacology       Date:  2020-02-11       Impact factor: 5.250

3.  Neurotensin Release from Dopamine Neurons Drives Long-Term Depression of Substantia Nigra Dopamine Signaling.

Authors:  Christopher W Tschumi; Harris E Blankenship; Ramaswamy Sharma; William B Lynch; Michael J Beckstead
Journal:  J Neurosci       Date:  2022-07-06       Impact factor: 6.709

4.  Analysis of the Underlying Mechanism of the Jiu Wei Zhen Xin Formula for Treating Generalized Anxiety Disorder Based on Network Pharmacology of Traditional Chinese Medicine.

Authors:  Heng Shao; Quan Gan; Zhuangfei Chen; Shasha Zhu; Yanqing Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-29       Impact factor: 2.650

5.  Neurotensin and dynorphin Bi-Directionally modulate CeA inhibition of oval BNST neurons in male mice.

Authors:  C P Normandeau; M L Torruella Suárez; P Sarret; Z A McElligott; E C Dumont
Journal:  Neuropharmacology       Date:  2018-09-21       Impact factor: 5.250

6.  RNA profiling of laser microdissected human trophoblast subtypes at mid-gestation reveals a role for cannabinoid signaling in invasion.

Authors:  Matthew Gormley; Oliver Oliverio; Mirhan Kapidzic; Katherine Ona; Steven Hall; Susan J Fisher
Journal:  Development       Date:  2021-10-19       Impact factor: 6.868

7.  Developmental or adult-onset deletion of neurotensin receptor-1 from dopamine neurons differentially reduces body weight.

Authors:  Patricia Perez-Bonilla; Jariel Ramirez-Virella; Pooja Menon; Eva Troyano-Rodriguez; Sydney K Arriaga; Anna Makela; Raluca Bugescu; Michael J Beckstead; Gina M Leinninger
Journal:  Front Neurosci       Date:  2022-09-23       Impact factor: 5.152

8.  Neurotensin: a neuropeptide induced by hCG in the human and rat ovary during the periovulatory period†.

Authors:  Linah Al-Alem; Muraly Puttabyatappa; Ketan Shrestha; Yohan Choi; Kathy Rosewell; Mats Brännström; James Akin; Misung Jo; Diane M Duffy; Thomas E Curry
Journal:  Biol Reprod       Date:  2021-06-04       Impact factor: 4.285

9.  Neurotensin receptor 1 deletion decreases methamphetamine self-administration and the associated reduction in dopamine cell firing.

Authors:  Sergio Dominguez-Lopez; Ramaswamy Sharma; Michael J Beckstead
Journal:  Addict Biol       Date:  2019-11-19       Impact factor: 4.093

10.  Genome-Wide DNA Methylation Analysis in Male Methamphetamine Users With Different Addiction Qualities.

Authors:  Liang Liu; Tao Luo; Huixi Dong; Chenxi Zhang; Tieqiao Liu; Xiangyang Zhang; Wei Hao
Journal:  Front Psychiatry       Date:  2020-10-23       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.